Government Relations News

Dan Jaffe, Group Executive Vice President of Government Relations for the Association of National Advertisers (ANA), today issued the following statement in response to the Federal Trade Commission’s (FTC) request for comment on the Rule Concerning the Use of Prenotification Negative Option Plans.

Don't miss out on Monday's webinar: Countdown to CCPA: Guidance for Members! This webinar will cover ANA's newly released guidance on how members can get ready for this extremely disruptive privacy law.

Highlights this week include newly published guidance on CCPA and the appellee brief filed by ANA and our co-plaintiffs in the HHS prescription drug advertising case.

ANA, along with co-plaintiffs Merck, Eli Lily, and Amgen, has filed with the U.S. Court of Appeals for the District of Columbia a brief asking it to uphold a D.C. District Court decision that invalidated a Department of Health and Human Services (HHS) rule requiring pharmaceutical drug makers to include the “list price” for drugs in DTC television ads.

Highlights this week include a new privacy bill from Reps. Eshoo and Lofgren, as well as, recently released guidance on influencers from the FTC.

Highlights this week include ANA's friend of the Court brief in CTIA v. Berkeley, the House vote on impeachment, and several important hearings.

WASHINGTON, D.C. (OCTOBER 31, 2019) – The ANA (Association of National Advertisers) has filed a “friend of the court” amicus brief with the U.S. Supreme Court in a key case being appealed from the U.S. Court of Appeals for the Ninth Circuit dealing with government mandated advertising disclosures.

Highlights this week include a Senate banking hearing on data ownership and the continued need for input in California.

Highlights this week include an FTC deadline extension and updates from California.

Highlights this week include the just released CCPA regulations from the CA Attorney General and a recap of the FTC's COPPA workshop.

Highlights this week include a Court decision on net neutrality, continuing activity in the states regarding privacy, and a major court case in Europe.

Highlights this week include a new ballot initiative on privacy in California as well as a new rulemaking from the FTC on negative option marketing.

A new regulatory impact analysis released by the California Attorney General’s Office has a number of highly troubling findings.

Highlights this week include a Senate Judiciary antitrust hearing and updates from California.

Highlights this week includes last minute activity on CCPA in California and an Advertising Coalition letter to the Senate Appropriations Committee on prescription drug ads.

Highlights this week include the final curtain for CCPA changes in California.

Highlights this week include an update on fast-moving developments in California.

Highlights this week include an update on where things stand in California on the CCPA, as well as efforts by State AGs and phone companies to stop robocalls.

Highlights this week include the first meetings of our working groups on CCPA and COPPA, as well as time running out for CCPA fixes in California.

Highlights this week include new federal legislation on data brokers and a report from the National Conference of State Legislatures summit.